Pfizer urges more efforts to reduce cancer patients’ pains, deaths, incidence

As part of its efforts to raise awareness of cancer and to encourage its prevention, detection and treatment, Pfizer joined the rest of the world to commemorate World Cancer Day.

World Cancer Day is a sin gular initiative under which the entire world can unite together in the fight against the global cancer epidemic.

Pfizer has partnered with Project PINK BLUE on awareness activities and setting up Abuja’s first breast cancer support group to join the advocacy on breast cancer.

Executive Director of Project PINK BLUE, Runcie C.W.

Chidebe, said:”Cancer has been defined with different pathetic axioms in Nigeria due to the severe pain, death, low survival rate and most painfully metastatic breast cancer. With the UICC Pfizer SPARC grant we have been able to start changing patients’ journey and access to palliative care in Nigeria. As the number of cancer patients grow, we must do everything we can to increase cancer survivors.”

This collaboration is aimed at providing increased awareness on cervical and breast cancers and reaching out to the government to take action against the disease.

Corporate Affairs Director Pfizer Nigeria,Margaret Olele, said: “Pfizer is committed to spreading knowledge and fostering hope in the fight against cervical and breast cancers as early detection can help in reducing the number of deaths.

“At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products.

“Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.To learn more about our commitments, please visit us at www.pfizer.com.”